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Abstract: The crystal structures of two oligopeptides containing di-n-propylglycine (Dpg) residues, Boc-Gly-Dpg-Gly-Leu-OMe
(1) and Boc-Val-Ala-Leu-Dpg-Val-Ala-Leu-Val-Ala-Leu-Dpg-Val-Ala-Leu-OMe (2) are presented. Peptide 1 adopts a type I′ β-
turn conformation with Dpg(2)–Gly(3) at the corner positions. The 14-residue peptide 2 crystallizes with two molecules in the
asymmetric unit, both of which adopt α-helical conformations stabilized by 11 successive 5 → 1 hydrogen bonds. In addition, a
single 4 → 1 hydrogen bond is also observed at the N-terminus. All five Dpg residues adopt backbone torsion angles (φ, ψ ) in
the helical region of conformational space. Evaluation of the available structural data on Dpg peptides confirm the correlation
between backbone bond angle N–Cα –C′ (τ ) and the observed backbone φ,ψ values. For τ > 106°, helices are observed, while fully
extended structures are characterized by τ < 106°. The mean τ values for extended and folded conformations for the Dpg residue
are 103.6° ± 1.7° and 109.9° ± 2.6°, respectively. Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd.
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INTRODUCTION
The conformational characteristics of α,α-dialkylated
amino acid residues when incorporated into peptide
chains have been extensively investigated [1–21]. The
prototype residue α-aminoisobutyric acid (Aib), which
contains a pair of methyl substitutants at the Cα car-
bon atom has been shown to strongly favor local helical
conformations, characterized by Ramachandran angles
φ ≈ 60° ± 20°, ψ ≈ 30° ± 20° [22–24]. Earlier studies
of the higher homologues of Aib, di-n-propylglycine
(Dpg) and di-n-butylglycine (Dbg) suggested that these
residues tend to favor fully extended conformations
φ ≈ 180°, ψ ≈ 180° [11,25–30]. These conclusions were
based on the crystal structures of homo-oligopeptides
containing Dpg residues [25]. Subsequent crystallo-
graphic studies, however, demonstrated that Dpg and
Dbg residues could also adopt helical conformations
and were readily incorporated into helical polypep-
tide structures [31–40]. Several crystallographic results
together with theoretical calculations suggested a cor-
relation between the backbone N–Cα –C′ bond angle (τ )
and the torsion angles about N–Cα (φ), Cα –C′ (ψ) bonds
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[25,27,38,40–43]. The demonstration of the coexis-
tence of both helical and extended conformation of
Dpg residues in the crystal structure of the tripeptide
Boc-Leu-Dpg-Val-OMe [43] underscores the fact that
the two distinct conformations may not differ apprecia-
bly in energy, in contrast to the case of Aib residues.
Limited structural information is available on the con-
formations of Dpg residues when placed in different
sequence contexts. We present in this article crystal
structures of a tetrapeptide Boc-Gly-Dpg-Gly-Leu-OMe
(1) and a 14-residue peptide Boc-Val-Ala-Leu-Dpg-Val-
Ala-Leu-Val-Ala-Leu-Dpg-Val-Ala-Leu-OMe (2). Peptide
2 crystallizes with two molecules in the asymmetric
unit, thereby providing conformational information on
four independent Dpg residues. These results establish
that all five Dpg residues adopt helical conformations
with τ values lying between 106.6° and 111.3°.
MATERIALS AND METHODS
Synthesis of Peptides 1 and 2
Dpg was synthesized from the di-n-propyl ketone in good yield
and purified by reported procedures [44]. The peptides 1 and
2 were synthesized by conventional solution phase procedures
using a fragment condensation strategy as described elsewhere
for related sequences [45]. The Boc group was used for
the N-terminal protection and the C-terminus was protected
as a methyl ester. The esterification of Dpg was effected
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Table 1 Crystal and diffraction parameters of peptides 1 and 2
Peptide 1 Peptide 2
Empirical formula C24H44N4O7 C78H142N14O17
Crystal habit Clear plate Clear needle
Crystal size (mm) 1.1 × 0.2 × 0.05 0.57 × 0.17 × 0.17
Crystallizing solvent Methanol-water Methanol-water
Space group P212121 P21
Cell parameters
a (A˚) 8.309(2) 12.851(2)
b (A˚) 12.970(3) 40.384(7)
c (A˚) 28.434(5) 19.367(3)
β (deg) 93.283(3)
Volume (A˚
3
) 3 064(1) 10 035(3)
Z 4 4
Molecules/asymmetric unit 1 2
Molecular weight 500.63 1548.1
Density (g/cm3)(calc.) 1.085 1.025
F(000) 1 088 3 376
Radiation (A˚) MoKα (λ = 0.7107) MoKα (λ = 0.7107)
Temperature (°C) 20 20
2θ max (deg) 53.74 46.5
Scan type ω ω
Measured reflections 23 293 105 809
Independent reflections 6 125 28 464
Unique reflections 3 558 14 652
Observed reflections (|Fo| > 4σ(|Fo|) 2 746 11 753
Final R (%) 6.99 12.16
wR2 (%) 17.09 22.95
Goodness of fit (S) 1.083 1.105

ρmax(e A˚
−3
) 0.277 0.235

ρmin(e A˚
−3
) −0.211 −0.168
No. of restraints/parameters 0/340 73/2033
Data to parameter ratio 8.1 : 1 5.8 : 1
Figure 1 Molecular conformation of peptide 1 in crystals.
The type I′ β-turn is stabilized by an intramolecular 4 → 1
hydrogen bond, shown as broken dotted line.
by passing dry HCl gas (until saturation) into solutions of
amino acids in dry methanol, followed by storage at −10 °C
for 3 days and then refluxing for 6 h. Deprotections were
performed using 98% formic acid and saponification for the
N- and C-terminus, respectively. Coupling reactions in the
preparation of dipeptides were mediated by DCC in DCM and
all other couplings were carried out in DMF in the presence of
DCC and HOBt. The final step in the synthesis of peptide 1 was
achieved by the fragment condensation of Boc-Gly-Dpg-OH
and H2N-Gly-Leu-OMe. Peptide 2was synthesized by fragment
condensation of Boc-Val-Ala-Leu-Dpg-Val-Ala-Leu-OH and
H2N-Val-Ala-Leu-Dpg-Val-Ala-Leu-OMe using DCC/HOBt as
coupling agents. Fragment Boc-Val-Ala-Leu-Dpg-Val-Ala-Leu-
OMe was synthesized by extending the fragment Leu-Dpg-
Val in both N- and C- terminal direction to overcome the
problem of low coupling yields. All the intermediate peptides
were characterized by 1H-NMR (80 MHz) and TLC, and used
without further purification. The final peptides were purified
by medium-pressure liquid chromatography (MPLC) on a C18
column (40–60 µ) followed by HPLC (C18, 5–10 µ), employing
methanol–water gradients. The homogeneity of the purified
peptides was ascertained by analytical HPLC. The purified
peptides were characterized by ESI-MS, and 500 MHz NMR
spectra. Peptide 1: MNa+obs = 523 Da, Mcal = 500 Da and
Peptide 2: MNa+obs = 1571 Da, Mcal = 1548 Da.
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Figure 2 (a) The molecular conformation of peptide 2 in crystals showing molecules A and B in the asymmetric unit. The
alternate positions of Dpg(4) in Molecule-A and Leu(7) in Molecule-B are indicated by thick broken lines. Hydrogen bonds are
shown as broken lines. (b) Schematic representation of the asymmetric unit of peptide 2. (c) Backbone superposition of the two
molecules in the asymmetric unit of peptide 2 (RMSD = 0.18 A˚). Molecule-A is shown in magenta while Molecule-B is shown in
cyan. The figure was generated using the program MOLMOL [51].
Figure 3 Packing of molecules in peptide1 projected down the crystallographic b-axis. The intermolecular hydrogen bonds are
indicated by dotted lines.
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Table 2 Torsion angles a (deg) of peptides 1 and 2
Residue φ ψ ω χ1 χ2
Peptide 1
Gly(1) −84.7b 5.3 172.0 — —
Dpg(2) 62.5 20.6 −178.0 −56.9, −62.5 −178.5, 173.1
Gly(3) 74.6 13.8 −178.0 — —
Leu(4) −96.5 161.8c 179.1d −62.7 −64.6, 169.3
Peptide 2
Molecule A
Val(1) −60f −42 −178 −62, 171 —
Ala(2) −61 −40 178 — —
Leu(3) −66 −49 −176 −175 64, −168
Dpg(4)e −54 −52 −178 53 (171), 163 (−75) −171(−174), −76(−180)
Val(5) −65 −43 173 −62, 167 —
Ala(6) −50 −45 180 — —
Leu(7) −71 −36 172 −69 −24, −174
Val(8) −60 −44 177 −64, 171 —
Ala(9) −58 −43 175 — —
Leu(10) −61 −48 −179 −84 −46, 172
Dpg(11) −53 −45 −172 52, 179 −177, −139
Val(12) −73 −43 −175 −66, 171 —
Ala(13) −76 −32 −179 — —
Leu(14) −108 1g −176h −54 −61, 178
Molecule-B
Val(1) −70i −35 −175 −71, 179 —
Ala(2) −68 −28 179 — —
Leu(3) −77 −39 175 −70 6, −176
Dpg(4) −54 −53 −176 64, 177 −176, 179
Val(5) −64 −41 −180 −68, 171 —
Ala(6) −62 −38 179 — —
Leu(7)e −72 −38 176 −69(179) −65(79), 170(−175)
Val(8) −67 −41 172 −66, 178 —
Ala(9) −53 −50 −180 — —
Leu(10) −57 −47 −174 −170 60, −174
Dpg(11) −59 −38 −178 58, 179 −166, 178
Val(12) −83 −28 178 −68, 84 —
Ala(13) −73 −43 −177 — —
Leu(14) −84 −28j −176k −70 −56, −180
a The torsion angles for rotation about bonds of the peptide backbone (φ, ψ and ω) and about bonds of the amino acid side chains
(χ1, χ2) as suggested by the IUPAC-IUB Commission on Biochemical Nomenclature [50]. Estimated standard deviations ∼0.5° for
peptide 1 and 1.0° for peptide 2.
b C0′ –N1–C1A–C1′.
c N4–C4A–C4′ –O0M.
d C4A–C4′ –O0M–C0M.
e Side chain is disordered. The values in the parenthesis are for the corresponding disordered position.
f C02–N1–C1A–C1′.
g N14–C14A–C14′ –O1M.
h C14A–C14′ –O1M–C1M.
i C04-N15-C15A-C15′.
j N28–C28A–C28′ –O2M.
k C28A–C28′ –O2M–C2M.
X-ray Diffraction
Single crystals suitable for X-ray diffraction were grown from
methanol–water mixture by slow evaporation for peptides 1
and 2. X-ray diffraction data for the peptide crystals were
collected at room temperature, from a dry crystal mounted on
a Bruker AXS SMART APEX CCD diffractometer using MoKα
radiation. The ω scan type was used.
Structure Solution and Refinement
Peptide 1 crystallized in the orthorhombic space group
P212121 with one molecule in the asymmetric unit. The
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Table 3 Hydrogen-bond parameters in peptides 1 and 2
Type Donor
(D)
Acceptor
(A)
N· · ·O
(A˚)
H· · ·O
(A˚)
C=O· · ·H
(deg)
C=O· · ·N
(deg)
O· · ·HN
(deg)
Peptide 1
Intramolecular
4 → 1 N4 O1 3.016 2.159 124.9 128.3 167.6
Intermolecular N1 O2a 3.137 2.615 129.2 130.3 120.8
Intermolecular N3 O3b 2.917 2.103 121.4 117.5 164.5
Peptide 2
Intramolecular
Molecule A
4 → 1 N3 O02 3.119 2.576 117.6 128.3 122.1
5 → 1 N4 O02 3.106 2.249 159.2 160.4 174.6
5 → 1 N5 O1 2.902 2.048 157.2 159.3 172.3
5 → 1 N6 O2 3.076 2.233 139.8 143.5 166.7
5 → 1 N7 O3 3.012 2.182 155.4 159.3 162.0
5 → 1 N8 O4 2.999 2.164 155.8 160.1 163.6
5 → 1 N9 O5 3.002 2.157 157.3 159.8 167.6
5 → 1 N10 O6 3.052 2.229 147.5 152.4 160.2
5 → 1 N11 O7 2.979 2.138 148.4 151.9 165.8
5 → 1 N12 O8 3.070 2.281 150.6 156.7 152.7
5 → 1 N13 O9 3.004 2.190 148.9 154.7 157.8
5 → 1 N14 O10 2.871 2.071 153.8 159.3 154.4
Molecule-B
4 → 1 N17 O04 3.254 2.603 110.2 119.0 133.4
5 → 1 N18 O04 3.317 2.469 150.5 153.3 169.0
5 → 1 N19 O15 2.971 2.117 158.7 160.6 172.0
5 → 1 N20 O16 3.067 2.257 138.6 144.6 157.2
5 → 1 N21 O17 3.042 2.227 151.3 156.7 158.2
5 → 1 N22 O18 3.132 2.302 151.4 156.0 162.1
5 → 1 N23 O19 2.924 2.072 156.3 158.8 170.8
5 → 1 N24 O20 2.981 2.152 145.4 150.3 161.9
5 → 1 N25 O21 3.031 2.221 144.7 150.6 156.8
5 → 1 N26 O22 3.284 2.497 146.8 151.7 152.4
5 → 1 N27 O23 3.085 2.307 149.2 156.9 150.5
5 → 1 N28 O24 3.010 2.168 157.4 160.0 166.0
Intermolecular
Molecule-A N1 O13c 2.880 2.027 108.0 107.4 171.2
Molecule-A N2 O12c 2.867 2.101 141.0 146.6 148.0
Molecule-B N15 O27d 2.908 2.049 120.9 120.5 177.0
Molecule-B N16 O26d 2.922 2.106 166.3 165.9 158.0
a Symmetry related by (x + 1, y, z).
b Symmetry related by (x + 1/2, −y + 3/2, −z).
c Symmetry related by (−x + 1, y + 1/2, −z + 1).
d Symmetry related by (−x, y + 1/2, −z). Estimated standard deviations in the hydrogen- bond lengths and angles are ∼0.005 A˚
and 0.3° for peptide 1 and 0.024 A˚ and 1.0° for peptide 2.
structure was determined by direct phase determination
using the program SHELXS-97 [46]. Refinement was carried
out against F2 with full-matrix least squares methods by
using SHELXL-97 [47]. At the end of isotropic refinement,
the R-factor was 19.72% and dropped to 14.90% after the
anisotropic refinement. Hydrogen atoms bonded to N1 (Gly);
N3, C3A (Gly); N4, C4A (Leu) were located from the difference
Fourier maps. The remaining hydrogen atoms, which could
not be located, were fixed geometrically in the idealized
positions and refined in the final cycle as riding over the
heavier atom to which they are bonded. The final R-factor
was 6.99% (wR2 = 17.09%) for 2746 observed reflections.
Peptide 2 crystalized in the monoclinic space group P21
with two molecules in the asymmetric unit. The asymmetric
unit in the crystal structure of 2 contains 218 nonhydrogen
atoms. Attempts to solve the structure by conventional direct
method technique using phase annealing [48] failed to yield
any fragments. The structure was solved by iterative dual
space direct methods using SHELXD [49]. Two fragments
were obtained containing 84 and 89 atoms. The remaining
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Figure 4 Packing of molecules (peptide 2) in crystals. Head-to-tail NH· · ·O hydrogen bonds stabilize the columns of helices,
which are shown by dotted lines. The arrows indicate the direction of the helix axes and mode of aggregation.
atoms were located from difference Fourier maps after several
cycles of refinement. Refinement was carried out with a
blocked full-matrix least squares method against F2 by using
SHELXL-97 [47]. The entire asymmetric unit was divided
into two blocks with one molecule forming each block.
All nonhydrogen atoms were initially refined isotropically.
Positional disorder was observed in the CG and CD atoms
of Dpg(4) in molecule-A and Leu(7) of molecule-B in the
asymmetric unit. The thermal parameters of these atoms were
refined isotropically till the final cycle of refinement and were
refined anisotropically in the final cycle. Seven atoms showed
‘nonpositive definite’ temperature factor during the course of
refinement. Hence these atoms were refined anisotropically
with the Uij components restrained to approximate isotropic
behavior (ISOR) [48] in the final cycle of refinement. The
hydrogen atoms were fixed geometrically in the idealized
positions and refined in the final cycle as riding over
the heavier atom to which they are bonded. The final
R-factor was 12.16% (wR2 = 22.95%) for 11 753 observed
reflections. The relevant crystallographic data collection
parameters and structure refinement details for peptides 1
and 2 are summarized in Table 1. Crystallographic data
(excluding structure factors) for peptides 1 and 2 have
been deposited with the Cambridge Crystallographic Data
Centre as supplementary publication numbers CCDC-656859
and CCDC-656860, respectively. Copies of the data can be
obtained, free of charge, on application to CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK, (fax: +44 1223 336033 or
E-mail: deposit@ccdc.cam.ac.uk).
RESULTS
Molecular conformations determined in crystals of the
tetrapeptide 1 and the 14-residue peptide 2 are shown
in Figures 1 and 2, respectively. The backbone and
side- chain torsion angles are listed in Table 2, and the
intra and intermolecular hydrogen-bond parameters
are listed in Table 3.
Boc-Gly-Dpg-Gly-Leu-OMe (1)
The tetrapeptide adopts a type I′ β-turn conformation
with Dpg(2) and Gly(3) occupying the i + 1 and i + 2
positions. The reverse turn structure is stabilized
by an intramolecular 4 → 1 hydrogen bond involving
the Gly(1) CO and Leu(4) NH groups. The Dpg(2)
residue adopts a left-handed helical (αL) conformation.
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y Peptide molecules in the crystal associate via two
intermolecular hydrogen bonds between symmetry-
related molecules (Figure 3). The Dpg(2) NH does
not participate in any intermolecular hydrogen bond
formation. Table 4 compares the conformations of Gly-
Dpg-Gly segments observed in crystal structures of
diverse model peptides. With the exception of tripeptide
acid Boc-Gly-Dpg-Gly-OH, in all other cases the Dpg
residue adopts an αR or αL conformation, with Dpg-
Gly unit adopting type I or I′ β-turn structures.
The conformation of the glycine residue preceding
the Dpg is somewhat more variable. Interestingly,
in the case of the tetrapeptide Boc-Gly-Dpg-Gly-Leu-
OMe (1) established in the present study, Gly(1)
adopts an αR conformation while Gly(3) adopts an
αL conformation. Switching the Gly(1) conformation to
the αL region would have resulted in a structure with
two intramolecular hydrogen bonds. In crystals, the
absence of this additional intramolecular interaction
is undoubtedly compensated by the formation of an
intermolecular hydrogen bond.
Boc-Val-Ala-Leu-Dpg-Val-Ala-Leu-Val-Ala-Leu-
Dpg-Val-Ala-Leu-OMe (2)
The 14-residue peptide exhibits a right-handed heli-
cal conformation over the entire length of the pep-
tide in both the molecules in the asymmetric unit
(Figure 2). Inspection of the hydrogen bond pattern
reveals an α-helix stabilized by 11 successive 5 → 1
hydrogen bonds in both the molecules. At the N-
terminus an additional 4 → 1 interaction between the
Boc CO and Leu(3) NH groups is also observed. The
Boc CO group participates in a bifurcated hydrogen-
bond interaction of the 4 → 1 and 5 → 1 types in
both the molecules. The Dpg(4) and Dpg(11) residues
adopt a right-handed helical (αR) conformations in
all the cases. In the asymmetric unit the two pep-
tide helices lie at an angle of 20.4° (Figure 2(b)).
Figure 2(c) shows a superposition of the two molecules
in the asymmetric unit of peptide 2 (RMSD = 0.18 A˚),
establishing that both the molecules have very sim-
ilar backbone conformations. A large deviation is
observed at the side chains of Leu(3) and Leu(10).
The molecules pack into the crystals as columns of
helices, approximately parallel to each other, held
together in each column by two intermolecular head-to-
tail N–H· · ·O hydrogen bonds (Figure 4, Table 3). Heli-
cal conformations observed in peptide 2 are remark-
ably similar to those established in the related 15-
residue peptide sequence Boc-Val-Ala-Leu-Aib-Val-Ala-
Leu-Val-Ala-Leu-Aib-Val-Ala-Leu-Aib-OMe, which con-
tains Aib residues at position 4, 11 and 15 [52].
Figure 5 shows the superposition of the structures of
the Aib analog and the Dpg containing peptide helices
determined in the present study. Clearly, the observed
structures are remarkably similar.
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Figure 5 (a) Superposition of peptide 2 of Molecule-A (black) with VALU15 (gray) (Backbone atom of residues 2–13 are used,
RMSD = 0.21 A˚) (b) Superposition of peptide 2 of Molecule-B (black) with VALU15 (gray) (Backbone atom of residues 2–13 are
used, RMSD = 0.19 A˚). VALU15: Boc-Val-Ala-Leu-Aib-Val-Ala-Leu-Val-Ala-Leu-Aib-Val-Ala-Leu-Aib-OMe.
Figure 6 (a) Distribution of torsion angles for Dpg residues in peptides. 35 Dpg residues from 22 peptide sequences.
(b) Three-dimensional φ-ψ-τ plot shows the correlation between bond angle N–Cα—C′ (τ ) and backbone torsion angles φ,ψ
in extended and folded conformations. The τ value 106° may be taken as the limiting value for extended and folded conformations.
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.
DISCUSSION
All five Dpg residues crystalographically characterized
in this study adopt helical conformations (αR or αL).
Table 5 list the backbone conformational angles and the
N–Cα—C′ bond angle (τ ) observed at the Dpg residues
in crystal structures deposited in Cambridge Structural
Database [53]. Figure 6 provides a cluster plot relating
the distribution in φ,ψ space with the bond angle (τ )
at the Cα carbon atom. There are significantly more
example of Dpg residues lying in the helical region of
φ,ψ space. This observation may, of course, reflect the
influence of the nature of the sequences studied thus
far, where isolated Dpg residues often have been placed
in the context of strongly helix-promoting sequences.
There appears to be a clear transition in backbone
conformation (φ,ψ) as a function of the bond angle
(τ ). Helices require a bond angle τ > 106°, while the
fully extended conformations are characterized by bond
angles between 101° and 106°. The mean τ values for
extended and folded conformations for the Dpg residue
are 103.6° ± 1.7° and 109.9° ± 2.6°, respectively. These
results have been rationalized by theoretical studies of
Dpg residues [27,41,42].
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